Live Chat

تداول Amgen AMGN

البيع
 شراء

Amgen live chart

5m 15m 30m 1h 4h 1d 1w

instrument_fundamentals

Weekly Search
Weekly
Daily
date إغلاق change معدل التغيير (%) instr__open مرتفع منخفض

Markets.com news

bitcoin dropping
Antonio Ferlito 2024 Aug 19, 16:05

Test News Article Arabic Only

CFD Trading BoE
French election results to drive European markets
markets.com Support Team 2024 Jul 04, 21:00

الأسبوع القادم: نتائج الانتخابات الفرنسية هامة بالنسبة للأسواق الأوروبية

الفوركس المؤشرات
Macron calls snap election, riles markets
markets.com Support Team 2024 Jun 29, 21:00

الأسبوع القادم: هل تتسبب فرنسا في أزمة جديدة لليورو؟

CPI
RBA, SNB, Bank of England rate decisions due next week
markets.com Support Team 2024 Jun 13, 21:00

الأسبوع القادم: البنك الأسترالي، البنك البريطاني.. الثبات أم التغيير؟

الفوركس المؤشرات

معلومات

الفارق الهامشي

1.72

الهامش (%)

0.6479 %

الرافعة المالية

1:10

فائدة الشراء بين ليلة وضحاها

-0.0597 %

فائدة البيع بين ليلة وضحاها

-0.0292 %

عملة

USD

ساعات التداول

السوق مغلق

الثلاثاء

14:31 - 20:59

الاثنين

14:31-20:59

الأربعاء

14:31-20:59

الخميس

14:31-20:59

الجمعة

14:31-20:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

141908705280

instr__shares_outstand

537532992

instr__earnings_date

1999-11-22

instr__dividend_date

2025-03-07

instr__ex_dividend_date

2025-02-14

instr__forward_annual_dividend_rate

9.52

instr__forward_annual_dividend_yield

0.0361

instr__eps

7.84

instrument_learn_more

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

related_instruments

الأصل
البيع
شراء
معدل التغيير (%)

تداول الآن

تداول الآن

تداول الآن

تداول الآن
view_all_instruments
Trustpilot
Live Chat